window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : July 18, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

personalised medicine

  • Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    Medicus files IND for genomics-enabled Phase 2 endometriosis trial

    Medicus Pharma has submitted an investigational new drug application in [...]

    June 11, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Genomics and sequencing,Therapeutic Areas

    23andMe study links genetics to GLP-1 weight loss outcomes and side effects

    This Nature-published study from the 23andMe Research Institute identifies genetic [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    Inaphaea BioLabs boosts precision oncology with new partnerships, advanced tumour models, and digital patient avatars

    Inaphaea BioLabs, the translational contract research organisation (CRO) of ValiRx [...]

    May 5, 2026
  • Drug Discovery & Development,Opinion & Events,Therapeutic Areas

    Abu Dhabi Biobank expands access to cord blood banking through NMC Healthcare partnership

    Abu Dhabi Biobank has partnered with NMC Healthcare to expand [...]

    May 5, 2026
  • Advanced Therapies,Drug Discovery & Development,Pharmaceuticals and therapeutics

    Adva Biotechnology and Autolomous launch digital pioneer program for scalable autologous cell therapy manufacturing

    Adva Biotechnology Ltd. and Autolomous Ltd. have announced a strategic [...]

    May 5, 2026
  • Advanced Therapies,Drug Discovery & Development,Manufacturing & Supply Chain,Opinion & Events

    Adva Biotechnology and Autolomous launch program to scale digital manufacturing of autologous cell therapies

    Adva Biotechnology and Autolomous have announced a collaboration to co-lead [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development,Medical devices,Pharmaceuticals and therapeutics

    Robots could slash cost of cell therapy by 74%, opening doors to wider access

    Multiply Labs and Universal Robots pioneer automated manufacturing for personalised [...]

    May 5, 2026
  • Drug Discovery & Development,Opinion & Events

    Vitamin D shown to reduce liver damage by activating TXNIP gene, study finds

    New study shows how the vitamin D/TXNIP axis modulates ductular [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Opinion & Events

    Linus Health unveils AI-powered advances in early Alzheimer’s detection and personalized brain health at AAIC 2025

    Digital assessments designed to support earlier diagnosis, streamline Alzheimer’s trial [...]

    May 5, 2026
  • Digital & Data,Drug Discovery & Development,Therapeutic Areas

    Biostate AI expands RNA-based precision medicine with new partnerships across China, India and the US

    Global collaborations boost dataset powering AI diagnostics for cancer, cardiovascular [...]

    May 5, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • FDA grants Fast Track status to SOTIO’s colorectal cancer ADC ahead of Phase 1/2 trial
    Categories: Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Therapeutic Areas
  • EpilepsyGTx partners with ClearPoint Neuro to support Phase 1 gene therapy trial
    Categories: Advanced Therapies, Clinical & Regulatory, Drug Delivery & Formulation, Research & Development
  • Skyhawk expands global Huntington’s disease trial following positive Phase 1/2 data
    Categories: Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top